IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE. FMHR. 2026;4(3):4646-4654. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/3859